Brain magnetic resonance imaging (MRI) revealed hyperintensity associated with thrombosis within the superior sagittal sinus (Fig. 1) ; this was confirmed by brain computed tomography angiography (Fig. 2) .
The patient was admitted to our intensive care unit, and treatment with intravenous heparin and methimazole 7.5 ㎎/day was commenced. After 3 days, his clinical condition gradually improved.
The focal neurological deficits disappeared after 
DISCUSSION
CVT is very uncommon condition and it's mortality rate is about 5%. 9 Instances of CVT in Graves' disease patients are also rare. Several previous studies suggested that hyperthyroidism is associated with increased risk of arterial and venous thromboembolism. 10 Observation from several case reports have shown the increased risk of CVT [5] [6] [7] [8] [9] [10] [11] [12] or pulmonary thromboembolism in patients with hyperthyroidism. 13, 14 Rau et al. reported a case of Graves' disease with CVT presented with headache and general weakness in old man. 6 He exhibited a high level of fibrinogen, low protein C activity, and atrial fibrillation. 6 Verberne et al. reported the case of Graves' disease with CVT presenting as a viral encephalitis in young woman through a factor VIII-medicated time, higher fibrinogen levels, increased levels of factor VIII and homocysteine, and decreased fibrinolytic activity during thyrotoxicosis in the previous studies. [5] [6] [7] 16 Increased fibrinogen levels and reduced levels of protein C were also associated with CVT development in Graves' disease patients. 6 The factor V Leiden mutation has been found in another case of thyrotoxic patient with CVT. 17 Our case also showed a reduced protein C and protein S level. Protein C inhibits coagulation by inactivating factors VIIIa and Va.
Patients with protein C deficiency may be at increased risk of thrombo-embolic events. 6 Apart from such changes in the coagulation system, several inherited or acquired risk factors for thrombosis are known in thyrotoxic patients. 
